Cardinal Health Files 8-K
Ticker: CAH · Form: 8-K · Filed: Apr 23, 2024 · CIK: 721371
| Field | Detail |
|---|---|
| Company | Cardinal Health INC (CAH) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulation-fd, financial-reporting
Related Tickers: CAH
TL;DR
Cardinal Health filed an 8-K, likely containing routine disclosures. Watch for details.
AI Summary
On April 23, 2024, Cardinal Health, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Cardinal Health is providing updates or disclosures required by the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain any specific financial or operational risks.
Key Players & Entities
- CARDINAL HEALTH INC (company) — Registrant
- Ohio (location) — State of incorporation
- Dublin (location) — City
FAQ
What is the primary purpose of this 8-K filing?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is April 23, 2024.
What is the company's state of incorporation?
The company is incorporated in Ohio.
What is the registrant's telephone number?
The registrant's telephone number is (614) 757-5000.
What is the SIC code for Cardinal Health, Inc.?
The Standard Industrial Classification (SIC) code is 5122 for Wholesale-Drugs Proprietaries & Druggists' Sundries.
Filing Stats: 613 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-04-23 06:42:45
Filing Documents
- cah-20240423.htm (8-K) — 28KB
- exhibit991-segmentresultsr.htm (EX-99.1) — 123KB
- 0000721371-24-000030.txt ( ) — 276KB
- cah-20240423.xsd (EX-101.SCH) — 2KB
- cah-20240423_lab.xml (EX-101.LAB) — 21KB
- cah-20240423_pre.xml (EX-101.PRE) — 12KB
- cah-20240423_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure As previously announced, beginning in the third quarter of fiscal year 2024, Cardinal Health, Inc. (the "Company") updated its organizational structure and re-aligned its operating and reporting segments to continue the company's simplification efforts, prioritize core operational execution and drive efficiency, accountability and transparency. In connection with these efforts, the Company is now voluntarily furnishing unaudited recast segment results under its new structure for each quarter of fiscal years 2022 and 2023 and the first two quarters of fiscal year 2024. These results are attached hereto as Exhibit 99.1 and incorporated herein by reference. The new reporting segments are the Pharmaceutical and Specialty Solutions segment and the Global Medical Products and Distribution segment. Separate from these segments are three operating segments, Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight Logistics, which are not significant enough individually to require reportable segment disclosure. These operating segments are reported as Other. These unaudited recast segment results do not represent a restatement of previously issued financial statements and do not impact the company's reported consolidated revenue, operating earnings/(loss), net earnings/(loss) or diluted earnings/(loss) per share for any of the previously reported periods. The recast segment results reflect changes in the elimination of inter-segment revenue and allocated corporate expenses for shared functions, which are driven by the reporting structure change. The company will prepare financial results on the basis of its updated structure beginning in the third quarter of fiscal year 2024. .
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits. Exhibit Number Exhibit Description 99.1 Unaudited revised quarterly segment financial results for fiscal years 2022, 2023 and the first two quarters of fiscal year 2024.
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: April 23, 2024 By: /s/ AARON E. ALT Aaron E. Alt Chief Financial Officer